Munich - Delayed Quote EUR

Mersana Therapeutics Inc (0M4.MU)

0.3306
+0.0138
+(4.36%)
At close: May 15 at 8:00:15 AM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
40,497
40,497
36,855
26,581
43
Operating Expense
113,833
113,833
207,812
230,348
168,901
Operating Income
-73,336
-73,336
-170,957
-203,767
-168,858
Net Non Operating Interest Income Expense
4,562
4,562
8,000
-445
-1,202
Other Income Expense
--
--
-8,713
--
--
Pretax Income
-68,774
-68,774
-171,670
-204,212
-170,060
Tax Provision
418
418
--
--
--
Net Income Common Stockholders
-69,192
-69,192
-171,670
-204,212
-170,060
Diluted NI Available to Com Stockholders
-69,192
-69,192
-171,670
-204,212
-170,060
Basic EPS
-0.56
--
-1.48
-2.18
-2.41
Diluted EPS
-0.56
--
-1.48
-2.18
-2.41
Basic Average Shares
122,539.5980
--
116,112.8910
93,654.2430
70,580.9490
Diluted Average Shares
122,539.5980
--
116,112.8910
93,654.2430
70,580.9490
Total Expenses
113,833
113,833
207,812
230,348
168,901
Net Income from Continuing & Discontinued Operation
-69,192
-69,192
-171,670
-204,212
-170,060
Normalized Income
-69,192
-69,192
-162,957
-204,212
-170,060
Interest Income
8,436
8,436
12,073
2,883
65
Interest Expense
3,874
3,874
4,073
3,328
1,267
Net Interest Income
4,562
4,562
8,000
-445
-1,202
EBIT
-64,900
-64,900
-167,597
-200,884
-168,793
EBITDA
-63,272
-63,272
-166,080
-199,957
-167,938
Reconciled Depreciation
1,628
1,628
1,517
927
855
Net Income from Continuing Operation Net Minority Interest
-69,192
-69,192
-171,670
-204,212
-170,060
Total Unusual Items Excluding Goodwill
0
0
-8,713
0
0
Total Unusual Items
0
0
-8,713
0
0
Normalized EBITDA
-63,272
-63,272
-157,367
-199,957
-167,938
Tax Rate for Calcs
0.0002
0.0002
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 3/26/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

IGC IGC Pharma, Inc.
0.2922
+0.55%
 
AZTR Azitra, Inc.
0.2805
+0.86%
 
ELEV Elevation Oncology, Inc.
0.2998
-12.24%
 
CYCC Cyclacel Pharmaceuticals, Inc.
2.2000
-5.17%
 
SPRY ARS Pharmaceuticals, Inc.
12.20
+0.79%
 
ABSI Absci Corporation
2.9600
+1.72%
 
HUMA Humacyte, Inc.
1.8900
+1.07%
 
RXRX Recursion Pharmaceuticals, Inc.
4.2500
-1.39%
 
CRSP CRISPR Therapeutics AG
36.31
+1.99%
 
NVAX Novavax, Inc.
6.29
+5.54%